6533b86dfe1ef96bd12ca005

RESEARCH PRODUCT

Efficacy of a genetically engineered Candida albicans tet-NRG1 strain as an experimental live attenuated vaccine against hematogenously disseminated candidiasis.

Ashok K. ChaturvediAnna L. LazzellStephen P. SavilleCarlos MonteagudoJose L. Lopez-ribot

subject

Microbiology (medical)Neuregulin-1T-LymphocytesClinical BiochemistryImmunologyBiologyVaccines AttenuatedMicrobiologyMiceImmunityCandida albicansImmunology and AllergyAnimalsCandida albicansFungal vaccineVaccines SyntheticAttenuated vaccineStrain (biology)Candidiasisbiochemical phenomena metabolism and nutritionDisseminated Candidiasisbiology.organism_classificationVaccine ResearchVirologySurvival AnalysisVaccinationImmunizationFungal Vaccines

description

ABSTRACT We report on the efficacy of the genetically engineered Candida albicans tet-NRG1 strain as an experimental live, attenuated vaccine against disseminated candidiasis in both immunocompetent and immunodeficient mice mostly dependent on T-cell immunity. This experimental vaccination model may represent an important tool to unravel the mechanisms of protective immunity during candidiasis.

10.1128/cvi.00480-08https://pubmed.ncbi.nlm.nih.gov/19144791